Poitiers Foodtrucks Festival Raises Funds for Pancreatic Cancer Research

Eighty percent of pancreatic cancers are diagnosed at a stage where surgery is no longer an option, according to the Nouvelle République. In response, the city of Poitiers is hosting a unique fundraising event—an annual food truck festival—that directs proceeds toward pancreatic cancer research. The initiative, now in its third year, has raised over €100,000 since its launch in 2024, with organizers emphasizing the urgency of early detection and treatment breakthroughs.

The festival, held in the Buxerolles district of Poitiers, brings together local chefs, food trucks, and volunteers to raise awareness while supporting the University Hospital of Poitiers, which treats pancreatic cancer patients in the region. According to Dr. Laurent Souquet, a gastroenterologist at the hospital, “Early diagnosis remains the only way to improve survival rates. This event helps fund research into biomarkers that could detect pancreatic cancer before it becomes inoperable.”

Pancreatic cancer remains one of the deadliest forms of cancer, with a five-year survival rate of just 12% in France, according to the French National Cancer Institute. The disease often progresses silently, with symptoms—such as jaundice, abdominal pain, or unexplained weight loss—appearing only in advanced stages. The World Health Organization estimates that fewer than 20% of patients are eligible for surgery at diagnosis, a figure that aligns with the Nouvelle République report.

Why is early detection so difficult?

Unlike breast or prostate cancers, pancreatic cancer lacks reliable screening methods. A 2023 study published in Nature highlighted that current imaging techniques—such as CT scans or MRIs—often miss early-stage tumors. “The pancreas is a small, deep organ, and by the time symptoms appear, the cancer has usually spread,” explained Dr. Souquet. The festival’s organizers hope to accelerate research into liquid biopsies, which could detect tumor DNA in blood samples before symptoms emerge.

France’s public health agency, Santé Publique France, reports that pancreatic cancer cases have risen by 15% over the past decade, driven partly by obesity and diabetes. The French National Institute of Health and Medical Research (Inserm) is leading a €5 million research consortium to explore genetic and environmental risk factors. The Poitiers festival’s fundraising complements these efforts, with proceeds specifically allocated to early detection projects.

How does the festival compare to other fundraising efforts?

The food truck festival model is gaining traction in France, with similar events in Lyon and Bordeaux raising funds for rare diseases. However, the Poitiers initiative stands out for its direct link to hospital-based research. While larger charities like the American Cancer Society rely on marathons or telethons, local events like this one often yield higher community engagement, according to a 2025 report in The Lancet Oncology. “Small-scale, hyper-local fundraising can drive faster action because the money stays within the healthcare system,” said Marie Dubois, a public health researcher at the University of Poitiers.

This year’s festival, scheduled for June 28–29, will feature collaborations with Michelin-starred chefs and regional producers. All proceeds go to the University Hospital Foundation, which has already allocated €30,000 from last year’s event to purchase advanced imaging equipment. “We’re not just raising money—we’re building a network of support around patients and their families,” said festival organizer Élodie Martin.

What comes next for pancreatic cancer research?

While the festival’s immediate impact is financial, its long-term goal is to shift public perception. Pancreatic cancer receives less than 3% of global cancer research funding, despite its high mortality rate. The UK’s Cancer Research UK has called for a “moonshot” approach to early detection, and France’s National Cancer Plan (2021–2025) includes a focus on pancreatic cancer as a priority area.

At the University Hospital of Poitiers, researchers are testing a new blood test developed by Inserm that could identify pancreatic cancer with 90% accuracy in high-risk patients. “If we can validate this test, it could change the game,” said Dr. Souquet. Meanwhile, the festival’s organizers are exploring partnerships with national charities to scale the model. “Our hope is that other cities will adopt this approach,” said Martin. “Every euro raised is a step closer to saving lives.”

For those interested in supporting the cause, the festival’s full schedule and donation links are available on the University Hospital of Poitiers website. The event is open to the public, with proceeds directly funding research into early detection methods.